White William Richard
Insider CIK 1778739 · AKRO Chief Financial Officer · IRON Director · VTYX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRON Disc Medicine, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 6,212 | — | $0 | 6,212 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 21,825 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 119,120 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 74,053 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 24,745 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,073 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 82,482 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 83,400 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 116,833 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,279 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 18,964 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,527 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 4,739 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 10,179 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 47,573 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-11 | 2025-09-12 | 659 | $43.02 | $28.4K | 57,752 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 58,411 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 1,634 | $54.84 | $89.6K | 57,521 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 2,804 | $54.00 | $151.4K | 59,155 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-12 | 2025-03-14 | 676 | $44.88 | $30.3K | 61,959 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 73,700 | — | $0 | 73,700 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 24,300 | — | $0 | 62,635 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 2,817 | $30.79 | $86.7K | 38,335 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 201 | — | $0 | 1,804 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 1,756 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 173 | $65.33 | $11.3K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 1,762 | $64.58 | $113.8K | 173 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 22 | $63.49 | $1.4K | 1,935 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 201 | $9.86 | $2.0K | 1,957 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 1,756 | $2.65 | $4.7K | 1,756 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-11-04 | 2024-11-05 | 7,136 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-11-04 | 2024-11-05 | 1,790 | $57.59 | $103.1K | 5,346 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-11-04 | 2024-11-05 | 7,136 | $45.69 | $326.0K | 7,136 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-11-04 | 2024-11-05 | 5,346 | $58.94 | $315.1K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-05 | 201 | — | $0 | 2,005 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 129 | $46.75 | $6.0K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-11-01 | 2024-11-05 | 201 | $9.86 | $2.0K | 201 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 72 | $45.68 | $3.3K | 129 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 201 | — | $0 | 2,206 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 40 | $50.45 | $2.0K | 129 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 201 | $9.86 | $2.0K | 201 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 50 | $51.51 | $2.6K | 79 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 79 | $52.53 | $4.1K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 32 | $49.03 | $1.6K | 169 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-13 | 639 | $26.18 | $16.7K | 41,152 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 1,756 | — | $0 | 1,756 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 201 | — | $0 | 2,407 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 50 | $51.54 | $2.6K | 10 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 1,560 | $49.43 | $77.1K | 397 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 1,756 | $2.65 | $4.7K | 1,957 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 201 | $9.86 | $2.0K | 201 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 10 | $52.28 | $523 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 337 | $50.29 | $16.9K | 60 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-27 | 2024-08-29 | 23,175 | — | $0 | 24,745 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-29 | 23,175 | $26.41 | $612.1K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-27 | 2024-08-29 | 23,175 | $21.09 | $488.8K | 64,966 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-26 | 2024-08-29 | 24,372 | — | $0 | 116,833 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-26 | 2024-08-29 | 18,116 | — | $0 | 47,920 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-26 | 2024-08-29 | 32,671 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-29 | 24,372 | $27.21 | $663.2K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-26 | 2024-08-29 | 24,372 | $19.87 | $484.3K | 66,163 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-29 | 32,671 | $27.21 | $889.0K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-26 | 2024-08-29 | 32,671 | $7.01 | $229.0K | 74,462 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-29 | 18,116 | $27.21 | $492.9K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-26 | 2024-08-29 | 18,116 | $21.09 | $382.1K | 59,907 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-08-01 | 2024-08-05 | 201 | — | $0 | 2,608 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 57 | $43.95 | $2.5K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-08-01 | 2024-08-05 | 201 | $9.86 | $2.0K | 201 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 144 | $43.24 | $6.2K | 57 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-07-25 | 2024-07-25 | 22,272 | — | $0 | 32,671 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-25 | 2024-07-25 | 20,481 | $27.66 | $566.5K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-25 | 2024-07-25 | 1,791 | $27.00 | $48.4K | 62,272 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-07-25 | 2024-07-25 | 22,272 | $7.01 | $156.1K | 64,063 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-07-24 | 2024-07-25 | 139,083 | — | $0 | 54,943 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-07-24 | 2024-07-25 | 139,083 | $7.01 | $975.0K | 180,874 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-24 | 2024-07-25 | 59,637 | $26.71 | $1.59M | 121,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-24 | 2024-07-25 | 79,446 | $27.19 | $2.16M | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-07-23 | 2024-07-25 | 500 | — | $0 | 194,026 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-07-23 | 2024-07-25 | 500 | $7.01 | $3.5K | 42,291 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-23 | 2024-07-25 | 500 | $28.01 | $14.0K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-07-16 | 2024-07-18 | 29,803 | — | $0 | 194,526 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-07-16 | 2024-07-18 | 29,803 | $7.01 | $208.9K | 76,602 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-16 | 2024-07-18 | 5,008 | $28.05 | $140.5K | 41,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-16 | 2024-07-18 | 29,803 | $28.05 | $836.0K | 46,799 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-03 | 201 | — | $0 | 2,809 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-07-01 | 2024-07-03 | 74 | $46.45 | $3.4K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-07-01 | 2024-07-03 | 201 | $9.86 | $2.0K | 201 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-07-01 | 2024-07-03 | 18 | $45.07 | $811 | 183 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-07-01 | 2024-07-03 | 109 | $45.92 | $5.0K | 74 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 2,831 | $22.64 | $64.1K | 46,799 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-06-03 | 2024-06-05 | 1,756 | — | $0 | 3,512 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-06-03 | 2024-06-05 | 201 | — | $0 | 3,010 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 107 | $35.15 | $3.8K | 1,850 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 1,755 | $36.10 | $63.4K | 95 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-06-03 | 2024-06-05 | 201 | $9.86 | $2.0K | 1,957 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-06-03 | 2024-06-05 | 1,756 | $2.65 | $4.7K | 1,756 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 95 | $36.72 | $3.5K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-03 | 201 | — | $0 | 3,211 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-05-01 | 2024-05-03 | 201 | $9.86 | $2.0K | 201 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 162 | $28.52 | $4.6K | 39 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 39 | $29.11 | $1.1K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 804 | — | $0 | 3,412 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 1,756 | — | $0 | 5,268 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 804 | $9.86 | $7.9K | 2,560 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 2,482 | $31.79 | $78.9K | 78 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 78 | $32.18 | $2.5K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 1,756 | $2.65 | $4.7K | 1,756 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 724 | $28.33 | $20.5K | 49,630 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2024-01-21 | 2024-01-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 611 | $20.76 | $12.7K | 50,354 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-12 | 2023-12-14 | 21,084 | — | $0 | 7,024 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-12 | 2023-12-14 | 5,427 | — | $0 | 4,216 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-12 | 2023-12-14 | 7,000 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 1,091 | $63.73 | $69.5K | 20,320 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 4,057 | $66.10 | $268.2K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 16,263 | $65.26 | $1.06M | 4,057 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-12 | 2023-12-14 | 21,084 | $2.65 | $55.9K | 21,084 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 12,100 | $59.44 | $719.2K | 21,411 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-12 | 2023-12-14 | 7,000 | $13.50 | $94.5K | 33,511 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-12 | 2023-12-14 | 5,427 | $9.86 | $53.5K | 26,511 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-12-08 | 2023-12-12 | 146,237 | — | $0 | 146,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2023-12-08 | 2023-12-12 | 32,497 | — | $0 | 50,965 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-11-09 | 2023-11-13 | 83,400 | — | $0 | 83,400 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-25 | 632 | $50.34 | $31.8K | 18,468 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-22 | 17,500 | — | $0 | 224,329 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-20 | 2023-06-22 | 20,777 | $55.00 | $1.14M | 19,100 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-20 | 2023-06-22 | 17,500 | $7.01 | $122.7K | 39,877 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-13 | 2023-06-15 | 606 | $55.16 | $33.4K | 22,377 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2023-06-09 | 2023-06-09 | 7,136 | — | $0 | 7,136 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 15,937 | — | $0 | 15,937 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | F Tax w/h | 2023-03-10 | 2023-03-14 | 641 | $43.47 | $27.9K | 22,983 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | M Exercise deriv | 2023-01-23 | 2023-01-24 | 33,353 | — | $0 | 119,120 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | S Sale | 2023-01-23 | 2023-01-24 | 5,048 | $34.33 | $173.3K | 28,305 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | S Sale | 2023-01-23 | 2023-01-24 | 7,027 | $35.91 | $252.3K | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | S Sale | 2023-01-23 | 2023-01-24 | 21,278 | $35.01 | $744.9K | 7,027 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | M Exercise | 2023-01-23 | 2023-01-24 | 33,353 | $6.03 | $201.1K | 33,353 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-28 | 2022-12-29 | 999 | — | $0 | 241,829 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-28 | 2022-12-29 | 999 | $7.01 | $7.0K | 24,623 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-28 | 2022-12-29 | 999 | $49.76 | $49.7K | 23,624 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-27 | 2022-12-29 | 19,001 | — | $0 | 242,828 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-27 | 2022-12-29 | 19,001 | $49.77 | $945.7K | 23,624 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-27 | 2022-12-29 | 19,001 | $7.01 | $133.2K | 42,625 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-16 | 2022-12-20 | 29,073 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-09 | 2022-12-13 | 86,379 | — | $0 | 86,379 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-12-09 | 2022-12-13 | 19,195 | — | $0 | 23,624 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-10-13 | 2022-10-17 | 20,000 | — | $0 | 261,829 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-10-13 | 2022-10-17 | 20,000 | $7.01 | $140.2K | 24,429 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-13 | 2022-10-17 | 20,000 | $39.82 | $796.4K | 4,429 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-13 | 29,074 | — | $0 | 58,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-09-13 | 2022-09-15 | 32,500 | — | $0 | 281,829 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 18,920 | $26.42 | $499.9K | 18,009 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-09-13 | 2022-09-15 | 32,500 | $7.01 | $227.8K | 36,929 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 13,580 | $27.87 | $378.5K | 4,429 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-13 | 29,074 | — | $0 | 29,074 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-06-30 | 2022-09-13 | 1,152 | $8.03 | $9.3K | 4,429 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2023-04-26 | 21,825 | — | $0 | 21,825 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 13,301 | — | $0 | 13,301 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-18 | 9,700 | — | $0 | 314,329 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-01-14 | 2022-01-18 | 9,700 | $22.03 | $213.7K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-01-14 | 2022-01-18 | 9,700 | $7.01 | $68.0K | 12,977 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-23 | 100 | — | $0 | 324,029 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-12-21 | 2021-12-23 | 100 | $22.00 | $2.2K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-12-21 | 2021-12-23 | 100 | $7.01 | $701 | 3,377 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-12-17 | 2021-12-20 | 3,200 | — | $0 | 324,129 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-12-17 | 2021-12-20 | 3,200 | $7.01 | $22.4K | 6,477 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 3,200 | $22.04 | $70.5K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-12-08 | 2021-12-10 | 87,221 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 6,500 | — | $0 | 327,329 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 6,500 | $22.24 | $144.6K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 6,500 | $7.01 | $45.6K | 9,777 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-10-01 | 2021-10-05 | 6,500 | — | $0 | 333,829 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 6,500 | $22.06 | $143.4K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-10-01 | 2021-10-05 | 6,500 | $7.01 | $45.6K | 9,777 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 8,559 | — | $0 | 340,329 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-09-01 | 2021-09-03 | 8,559 | $7.01 | $60.0K | 11,836 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-09-01 | 2021-09-03 | 8,559 | $24.00 | $205.4K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-08-02 | 2021-08-04 | 4,441 | — | $0 | 348,888 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-08-02 | 2021-08-04 | 4,441 | $7.01 | $31.1K | 7,718 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-04 | 4,441 | $22.03 | $97.8K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-07-06 | 2021-07-08 | 6,500 | — | $0 | 353,329 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-07-06 | 2021-07-08 | 6,500 | $7.01 | $45.6K | 9,777 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-07-06 | 2021-07-08 | 6,500 | $24.52 | $159.4K | 3,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-05-03 | 2021-05-04 | 4,200 | — | $0 | 359,829 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-05-03 | 2021-05-04 | 4,200 | $7.01 | $29.4K | 6,470 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 4,200 | $30.56 | $128.4K | 2,270 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-04-01 | 2021-04-05 | 50,000 | — | $0 | 364,029 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 48,851 | $28.63 | $1.40M | 3,419 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-04-01 | 2021-04-05 | 50,000 | $7.01 | $350.5K | 52,270 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 1,149 | $29.29 | $33.7K | 2,270 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-12-08 | 2020-12-09 | 77,580 | — | $0 | 77,580 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2020-06-30 | 2020-12-09 | 1,245 | $17.07 | $21.3K | 2,270 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2019-12-31 | 2020-01-03 | 1,025 | $18.87 | $19.3K | 1,025 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2019-12-13 | 2019-12-13 | 85,000 | — | $0 | 85,000 | SEC↗ |